TBX1 and cancer: The BN-Brachyury vaccine is a recombinant poxviral vaccine targeting the transcription factor brachyury, which is overexpressed in advanced cancers and associated with drug resistance, epithelial–mesenchymal transition (EMT), and metastatic potential.